ATAI Life Sciences BV (ATAI) — Capital Reinvestment Ratio

Latest as of June 2021: 0.15x

ATAI Life Sciences BV (ATAI) has a Capital Reinvestment Ratio of 0.15x as of June 2021, meaning it reinvests 0% of its operating cash flow ($1.90 Million) in capital expenditures ($278.00K). Check ATAI Life Sciences BV tangible book value ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.15x

Capex / Operating Cash Flow

Operating Cash Flow

$1.90 Million

USD

Capital Expenditures

$278.00K

USD

Data as of

Jun 2021

Most recent filing

Annual Capital Reinvestment Ratio for ATAI Life Sciences BV (None–None)

Year-by-year Capital Reinvestment Ratio for ATAI Life Sciences BV from None to None. See ATAI free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow